Department of Biomedical Science, Research Institute of Bioscience & Biotechnology, Hallym University, Chuncheon 24252, Republic of Korea.
Department of Veterinary Medicine, Institute of Veterinary Science, Chungnam National University, Daejeon 34134, Republic of Korea.
Int J Mol Sci. 2023 Feb 1;24(3):2767. doi: 10.3390/ijms24032767.
Glutathione S-transferase alpha 2 (GSTA2), a member of the glutathione S-transferase family, plays the role of cellular detoxification against oxidative stress. Although oxidative stress is related to ischemic injury, the role of GSTA2 against ischemia has not been elucidated. Thus, we studied whether GSTA2 prevents ischemic injury by using the PEP-1-GSTA2 protein which has a cell-permeable protein transduction domain. We revealed that cell-permeable PEP-1-GSTA2 transduced into HT-22 cells and markedly protected cell death via the inhibition of reactive oxygen species (ROS) production and DNA damage induced by oxidative stress. Additionally, transduced PEP-1-GSTA2 promoted mitogen-activated protein kinase (MAPK), and nuclear factor-kappaB (NF-κB) activation. Furthermore, PEP-1-GSTA2 regulated Bcl-2, Bax, cleaved Caspase-3 and -9 expression protein levels. An in vivo ischemic animal model, PEP-1-GSTA2, markedly prevented the loss of hippocampal neurons and reduced the activation of microglia and astrocytes. These findings indicate that PEP-1-GSTA2 suppresses hippocampal cell death by regulating the MAPK and apoptotic signaling pathways. Therefore, we suggest that PEP-1-GSTA2 will help to develop the therapies for oxidative-stress-induced ischemic injury.
谷胱甘肽 S-转移酶 α2(GSTA2)是谷胱甘肽 S-转移酶家族的成员,在细胞对抗氧化应激的解毒中发挥作用。尽管氧化应激与缺血性损伤有关,但 GSTA2 对抗缺血的作用尚未阐明。因此,我们使用具有细胞穿透蛋白转导结构域的 PEP-1-GSTA2 蛋白研究了 GSTA2 是否可以通过预防缺血性损伤。我们发现细胞穿透的 PEP-1-GSTA2 转导到 HT-22 细胞中,并通过抑制氧化应激引起的活性氧(ROS)产生和 DNA 损伤,显著保护细胞死亡。此外,转导的 PEP-1-GSTA2 促进丝裂原活化蛋白激酶(MAPK)和核因子-κB(NF-κB)的激活。此外,PEP-1-GSTA2 调节 Bcl-2、Bax、裂解的 Caspase-3 和 -9 表达蛋白水平。在体内缺血动物模型中,PEP-1-GSTA2 显著防止海马神经元丢失,并减少小胶质细胞和星形胶质细胞的激活。这些发现表明 PEP-1-GSTA2 通过调节 MAPK 和凋亡信号通路抑制海马细胞死亡。因此,我们认为 PEP-1-GSTA2 将有助于开发针对氧化应激诱导的缺血性损伤的治疗方法。